An explainable deep learning framework for identifying distributed, individualized neurodegeneration signatures of NPS burden across the AD continuum is introduced.
Abstract
Neuropsychiatric symptoms (NPS) are increasingly recognized as critical components of the disease progression in Alzheimer's disease (AD), yet their relationship with neurodegeneration remain poorly characterized. We investigated the multivariate relationships between structural MRI (sMRI)-based regional neurodegenerative biomarkers and NPS using the Alzheimer's Disease Neuroimaging Initiative (ADNI) and Knight Alzheimer Disease Research Center (Knight-ADRC) cohorts (N = 1,756). The machine learning regression models were compared for NPS prediction, and the best-performing deep neural network (named NPSNet) was integrated with three feature-importance methods: SHapley Additive exPlanations (SHAP), Local Interpretable Model-agnostic Explanations (LIME), and Layer-wise Relevance Propagation (LRP). To establish a known ground truth, we introduced predefined regional perturbations into semi-simulated data and tested whether NPSNetSHAP, NPSNetLIME, and NPSNetLRP could recover them. The NPSNet strongly predicted NPS scores (pooled Spearman {rho} = 0.927, p < 2.2 x 10-3; fold-wise {rho} = 0.912-0.963) and NPSNetSHAP recovered all 100% perturbed regions, compared with 90% for NPSNetLIME and 40% for NPSNetLRP. In the experimental data (N = 1,756), the NPSNet produced the highest held-out correlation ({rho} = 0.387, p = 1.7 x 10-{superscript 1}), exceeding gradient boosting ({rho} = 0.301), support vector regression ({rho} = 0.266), and others ({rho} < 0.266). NPSNetSHAP identified individual-level regional contribution patterns relevant to NPS predictions. Comparing NPSNetSHAP attributions between cognitively normal (CN) and mild cognitive impairment (MCI)/AD groups revealed distributed multivariate neurodegenerative signatures of NPS, with the largest differences between CN and AD participants. This study introduces an explainable deep learning framework for identifying distributed, individualized neurodegeneration signatures of NPS burden across the AD continuum.
R-GenIMA, an interpretable multimodal large language model that pairs a region-of-interest vision transformer with genetic prompting to jointly analyze structural MRI and single nucleotide polymorphisms, shows that interpretable multimodal AI can integrate imaging and genetics to reveal disease mechanisms.
Kun Zhao, Si-Yuan Dai, Ying-Ying Zhang et al.· Frontiers in Radiology· 0 citations
Identifying progressive dementia during its prodromal stage is a challenging yet critical task for healthcare providers. Traditional clinical assessments are often not sensitive enough to detect warning signs of cognitive decline. Machine learning (ML) methods have shown promise in modeling clinical trajectories associ...
A. Gautier, L. Zheng, B. Schreurs· medRxiv· 0 citations
Recent progress in AI-driven approaches for AD detection is discussed and the importance of interdisciplinary strategies to facilitate earlier diagnosis, improve patient outcomes, and support more effective management of Alzheimer's disease is underscored.
Hakar Hasan Rasheed, Naaman Omar Yaseen· Academic Journal of Internat...· 0 citations
Neurodegenerative diseases, particularly Alzheimer's Disease and Parkinson's Disease, are rapidly increasing as one of the leading causes of disability, cognitive decline, and death among the elderly population worldwide. Accurately predicting long-term disease progression remains a significant research challenge due t...
Md. Ariful Islam, Moloy Biswas, Alif Laila et al.· Journal of Information Techn...· 0 citations
Dementia is a major and growing global health burden, with Alzheimer's disease (AD) accounting for most cases. Timely and accurate diagnosis is central to managing this burden and increasingly depends on integrating complementary clinical and imaging information. Multimodal deep learning can combine these modalities fo...
Yusuf Brima, M. Atemkeng, L. Namamula et al.· arXiv.org· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.